Lilly Asia Ventures
About Lilly Asia Ventures
Lilly Asian Ventures is an investment firm that invests in promising life science companies.
Investment focus
Stages
Sectors
Portfolio (6 in our database)
Singlera GenomicsSinglera Genomics is a fast growing company focusing on non-invasive genetic testing.Series B · $275M raisedTmunity TherapeuticsTmunity Therapeutics is developing novel products to unleash the immunological potential of T cellsSeries B · $230M raisedAnsun BioPharmaAnsun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.Series B · $213M raisedKSQ TherapeuticsKSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.Series C · $156M raisedArriVent BiopharmaArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products.Series A · $150M raisedCrown BioscienceCrownBio is helping provide clarity of action in the fight against cancer and diabetes.Acquired · $62M raised